People · Operator
Named in public records as an officer, director or promoter · active 2009–2019 · Pharmaceuticals, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Secura Bio Holdings, Inc. | — | Pharmaceuticals | Series D+ | $105.0M | $3.7B | 2019 |
| Gevo, Inc. | — | Other Energy | Series B | $97.3M | $302.9M | 2009 |
| Secura Bio, Inc. | — | Pharmaceuticals | Series C | $50.0M | $1.8B | 2019 |
Brett Lund at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brett Lund on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Juan Estruch | 2 | 3 |
| Mark Spring | 2 | 2 |
| Joseph Limber | 2 | 2 |
| Samir Kaul | 1 | 32 |
| Mark Smith | 1 | 28 |
| Bruce Smith | 1 | 9 |
| Ganesh Kishore | 1 | 7 |
| Stacy Smith | 1 | 4 |
| Patrick Gruber | 1 | 3 |
| Veronique Hervouet | 1 | 2 |
| Frances Arnold | 1 | 2 |
| Jeffrey Ferrell | 1 | 2 |
| Christopher Ryan | 1 | 2 |
| Mike Willis | 1 | 2 |
| Shai Weiss | 1 | 1 |
| Greg Roda | 1 | 1 |
| Gary Mize | 1 | 1 |
| Ruth Dreessen | 1 | 1 |
| Carlos Cabrera | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.